Related Experiment Video

Updated: May 27, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

S6K1 and 4E-BP1 are independent regulated and control cellular growth in bladder cancer

Roman Nawroth1, Florian Stellwagen, Wolfgang A Schulz

  • 1Department of Urology, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany. roman.nawroth@lrz.tum.de

Plos One
|November 24, 2011
PubMed

Insights

Aberrant PI3K/Akt/mTOR and MAPK signaling drive urothelial carcinoma. Targeting 4E-BP1 alongside PI3K and mTOR offers a promising multi-targeting strategy for cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Aberrant activation of phosphatidylinositol-3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) and mitogen-activated protein kinase (MAPK) pathways is implicated in urothelial carcinoma (UC) tumorigenesis.
  • Limited success of anti-tumor therapy targeting mTOR alone necessitates further investigation into these pathways.

Purpose of the Study:

  • To elucidate the molecular mechanisms of PI3K/Akt/mTOR and MAPK signaling in UC.
  • To evaluate the efficacy of targeting specific components and combinations of these pathways for anti-cancer therapy.

Main Methods:

  • Utilized small chemical inhibitors and siRNA technology to interfere with molecular components of PI3K/Akt/mTOR and MAPK pathways.
  • Analyzed effects on molecular activation status, cell growth, proliferation, and apoptosis in UC cell lines.

Main Results:

  • Constitutive PI3K activation was observed in most UC cell lines.
  • mTOR inhibition alone did not affect 4E-BP1 phosphorylation, indicating an alternative PI3K-dependent regulation.
  • Simultaneous inhibition of S6K1 and 4E-BP1 effectively suppressed cell growth.
  • MEK1/2 inhibition activated Akt but not mTOR/S6K1 or 4E-BP1, suggesting crosstalk.

Conclusions:

  • 4E-binding protein 1 (4E-BP1) is a potential novel therapeutic target and stratification marker for UC.
  • A multi-targeting approach involving PI3K, mTORC1/2, and MAPK inhibition may enhance anti-cancer efficacy in UC.

More Related Videos

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

An Orthotopic Bladder Cancer Model for Gene Delivery Studies07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...